Drugs / Quisinostat
Quisinostat
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06824662 | Sep 2025 → Jul 2026 overdue | glioblastoma | Nader Sanai | Active not recruiting | No outcome recorded |
| Phase 14 trials | ||||||
| Phase 1 | NCT02728492 | Aug 2013 → Dec 2015 | malignant epithelial tumor of ovary, non-small cell lung carcinoma | NewVac LLC | Completed | No outcome recorded |
| Phase 1 | NCT01464112 | Sep 2011 → Nov 2013 | plasma cell myeloma | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 1 | NCT00676728 | Dec 2008 → Sep 2011 | myelodysplastic syndrome | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Terminated | No outcome recorded |
| Phase 1 | NCT00677105 | Aug 2007 → Sep 2011 | lymphoma | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT06932757 | May 2025 → May 2030 expected | uveal melanoma | University of Miami | Recruiting | No outcome recorded |
| Phase 2 | NCT02948075 | Sep 2015 → Dec 2016 | ovarian carcinoma | NewVac LLC | Completed | No outcome recorded |
| Phase 2 | NCT01486277 | Nov 2011 → Nov 2014 | primary cutaneous T-cell lymphoma | Janssen Research & Development, LLC | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quisinostat | “Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myeloma.” PMID 26758913 ↗ Jan 2016 |
| Known as | JNJ-26481585 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00676728 ↗ |
| Known as | JNJ-26481585-AAC | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105763 ↗ |
| Known as | QUISINOSTAT HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105763 ↗ |
| Action | Inhibit | “Histone-deacetylase Inhibitor JNJ-26481585” NCT00676728 ↗ |
| Modality | Small molecule | — CHEMBL2105763 ↗ |
| Route | Oral | “4 mg oral capsule is administered once daily” NCT00676728 ↗ |